Paramount Global Statistics
Total Valuation
Merck & Co. has a market cap or net worth of MXN 3.74 trillion. The enterprise value is 4.23 trillion.
Market Cap | 3.74T |
Enterprise Value | 4.23T |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
Current Share Class | 2.50B |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.77% |
Shares Change (QoQ) | -0.71% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.49B |
Valuation Ratios
The trailing PE ratio is 12.07 and the forward PE ratio is 8.70.
PE Ratio | 12.07 |
Forward PE | 8.70 |
PS Ratio | 3.11 |
PB Ratio | 4.04 |
P/TBV Ratio | 16.22 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.91, with an EV/FCF ratio of 15.25.
EV / Earnings | 13.68 |
EV / Sales | 3.59 |
EV / EBITDA | 7.91 |
EV / EBIT | 9.49 |
EV / FCF | 15.25 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.
Current Ratio | 1.42 |
Quick Ratio | 0.82 |
Debt / Equity | 0.72 |
Debt / EBITDA | 1.23 |
Debt / FCF | 2.40 |
Interest Coverage | 18.86 |
Financial Efficiency
Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.13%.
Return on Equity (ROE) | 35.42% |
Return on Assets (ROA) | 13.07% |
Return on Invested Capital (ROIC) | 18.13% |
Return on Capital Employed (ROCE) | 26.30% |
Revenue Per Employee | 16.21M |
Profits Per Employee | 4.18M |
Employee Count | 75,000 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.20 |
Taxes
In the past 12 months, Merck & Co. has paid 51.75 billion in taxes.
Income Tax | 51.75B |
Effective Tax Rate | 14.32% |
Stock Price Statistics
The stock price has decreased by -30.78% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.
Beta (5Y) | 0.39 |
52-Week Price Change | -30.78% |
50-Day Moving Average | 1,520.46 |
200-Day Moving Average | 1,771.08 |
Relative Strength Index (RSI) | 44.52 |
Average Volume (20 Days) | 4,194 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.91 |
Income Statement
In the last 12 months, Merck & Co. had revenue of MXN 1.20 trillion and earned 309.39 billion in profits. Earnings per share was 122.30.
Revenue | 1.20T |
Gross Profit | 928.69B |
Operating Income | 453.73B |
Pretax Income | 361.38B |
Net Income | 309.39B |
EBITDA | 538.18B |
EBIT | 453.73B |
Earnings Per Share (EPS) | 122.30 |
Balance Sheet
The company has 162.60 billion in cash and 667.62 billion in debt, giving a net cash position of -505.02 billion.
Cash & Cash Equivalents | 162.60B |
Total Debt | 667.62B |
Net Cash | -505.02B |
Net Cash Per Share | n/a |
Equity (Book Value) | 925.18B |
Book Value Per Share | 369.10 |
Working Capital | 207.97B |
Cash Flow
In the last 12 months, operating cash flow was 349.52 billion and capital expenditures -71.89 billion, giving a free cash flow of 277.63 billion.
Operating Cash Flow | 349.52B |
Capital Expenditures | -71.89B |
Free Cash Flow | 277.63B |
FCF Per Share | n/a |
Margins
Gross margin is 77.41%, with operating and profit margins of 37.82% and 25.79%.
Gross Margin | 77.41% |
Operating Margin | 37.82% |
Pretax Margin | 30.12% |
Profit Margin | 25.79% |
EBITDA Margin | 44.86% |
EBIT Margin | 37.82% |
FCF Margin | 23.14% |
Dividends & Yields
This stock pays an annual dividend of 62.56, which amounts to a dividend yield of 4.18%.
Dividend Per Share | 62.56 |
Dividend Yield | 4.18% |
Dividend Growth (YoY) | 18.07% |
Years of Dividend Growth | 1 |
Payout Ratio | 51.15% |
Buyback Yield | 0.77% |
Shareholder Yield | 4.94% |
Earnings Yield | 8.28% |
FCF Yield | 7.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 4.34 and a Piotroski F-Score of 6.
Altman Z-Score | 4.34 |
Piotroski F-Score | 6 |